Skip to main content
HairCited

Androgenetic alopecia.

Nina Otberg, Andreas M Finner, Jerry Shapiro
Review Endocrinology and metabolism clinics of North America 2007 33 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D17543725'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
Review
Population
None
Intervention
Androgenetic alopecia. None
Comparator
None
Primary Outcome
Androgenetic alopecia.
Effect Direction
Mixed
Risk of Bias
Unclear

Abstract

Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (eg, finasteride, minoxidil, or a combination of both), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Combination with hair restoration surgery leads to best results in suitable candidates. Physicians who specialize in male health issues should be familiar with this common condition and all the available approved treatment options.

TL;DR

Physicians who specialize in male health issues should be familiar with this common condition and all the available approved treatment options.

Used In Evidence Reviews

Similar Papers